Maternal hypoparathyroidism related transient normocalcemic hyperparathyroidism in newborns: case report

Maternal hypoparathyroidism related transient normocalcemic hyperparathyroidism in newborns: case report

Maternal hypoparathyroidism causes enlargement in fetal parathyroid glands and hyperparathyroidism. This kind of neonatal hyperparathyroidism may lead tohypercalcemia. Normocalcemia may be observed in some cases. This temporary presentation of hyperparathyroidism generally recovers in a few days after birth as the infant takes enough amount of calcium and phosphorus. Especially significant intrauterine growth retardation and mortality rates are high in infants born from mothers with poorly controlled or untreated hypoparathyroidism. Contrary to the severe hyperparathyroidism of the newborn, these infants often have low birth weight, suppressed or normal serum calcium levels and normal or a little high serum phosphorus levels. The reasons for this difference between the two groups are unknown. In this article, literature was examined by presenting the case of an infant who had transient normocalcemic hyperparathyroidism and the mother who had thyrodectomy and hypoparathyroid symptoms and inadequate treatment during pregnancy.

___

  • Wills MR, Pak CY, Hammond WG, Bartter FC. Normocalcemic primary hyperparathyroidism. Am J Med 1969;47(3):384-91.
  • Díaz-Soto G, Julián MT, Puig-Domingo M. Normocalcemic primaryhyperparathyroidism: a newly emerging disease needing therapeutic intervention. Hormones (Athens) 2012;11(4):390-6.
  • Reh CM, Hendy GN, Cole DE, Jeandron DD. Neonatal hyperparathyroidism with a heterozygous calciumsensing receptor (CASR) R185Q mutation: clinical benefit from cinacalcet. J Clin Endocrinol Metab 2011;96(4):E707-12.
  • Kovacs CS. Calcium, phosphorus, and bone metabolism in the fetus and newborn. Early Hum Dev 2015;91(11):623-8.
  • Krysiak R, Kobielusz-Gembala I, Okopien B. Hypoparathyroidism in pregnancy.Gynecol Endocrinol 2011;27(8):529-32.
  • Krysiak R, Okopien B, Bołdys A. [Autoimmune polyglandular syndromes]. Przegl Lek 2008;65(9):393- 400.
  • Krysiak R, Kobielusz-Gembala I, Okopien B. Hypoparathyroidism in pregnancy. Gynecol Endocrinol 2011;27(8):529-32.
  • Shoback D. Clinical practice. Hypoparathyroidism. N Engl J Med 2008;24;359(4):391-403.
  • Savani R, Mimouni F, Tsang R. Maternal and neonatal hyperparathyroidism as a consequence of maternal renal tubular acidosis. Pediatrics 1993; 91: 661–3.
  • Rodriguez-Soriano J, Garcia-Fuentes M, Vallo A, et al. Hypercalcemia in neonatal distal renal tubular acidosis. Pediatr Nephrol 2000;14:354–5.
  • Loughead J, Mughal F, Mimouni F, et al. Spectrum and natural history of congenital hyperparathyroidism secondary to maternal hypocalcemia. Am J Perinatol 1990;7:350–5.
  • Hsu SC, Levine MA. Perinatal calcium metabolism: Physiology and pathophysiology. Semin Neonatol 2004;9:23–36.
İnönü Üniversitesi Turgut Özal Tıp Merkezi Dergisi-Cover
  • ISSN: 1300-1744
  • Yayın Aralığı: Yılda 4 Sayı
  • Yayıncı: İnönü Üniversitesi Tıp Fakültesi